| 11/12/2026 3:20 PM | Rani Therapeutics (1856725) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/12/2026 2:33 PM | Invus Global Management, LLC (2005369) Filed by Rani Therapeutics (1856725) Subject | Form SCHEDULE 13G/A | |
| 11/09/2026 4:22 PM | Rani Therapeutics (1856725) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/09/2026 4:00 PM | Rani Therapeutics (1856725) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/29/2026 3:42 PM | Imran Talat (1869579) Reporting Rani Therapeutics (1856725) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/29/2026 3:36 PM | Javadi Alireza (2123843) Reporting Rani Therapeutics (1856725) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2026 3:46 PM | RA CAPITAL MANAGEMENT, L.P. (1346824) Filed by Rani Therapeutics (1856725) Subject | Form SCHEDULE 13G/A | |
| 08/13/2026 3:16 PM | Rani Therapeutics (1856725) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/04/2026 7:48 PM | Gilson Michelle (1930862) Reporting Rani Therapeutics (1856725) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 08/04/2026 7:51 PM | Gilson Michelle (1930862) Reporting Rani Therapeutics (1856725) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/04/2026 7:05 AM | Rani Therapeutics (1856725) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for RANI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Rani Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 07/31/2026 9:42 AM | Rani Therapeutics (1856725) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G/A | |
| 07/21/2026 6:24 PM | Javadi Alireza (2123843) Reporting Rani Therapeutics (1856725) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/21/2026 5:25 PM | Imran Talat (1869579) Reporting Rani Therapeutics (1856725) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/21/2026 5:29 PM | Imran Talat (1869579) Reporting Rani Therapeutics (1856725) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/21/2026 3:51 PM | Maestas Nicholas (1871423) Reporting Rani Therapeutics (1856725) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/15/2026 4:09 PM | Rani Therapeutics (1856725) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 07/08/2026 3:05 PM | Maestas Nicholas (1871423) Reporting Rani Therapeutics (1856725) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 06/05/2026 5:14 PM | Imran Talat (1869579) Reporting Rani Therapeutics (1856725) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2026 5:17 PM | Javadi Alireza (2123843) Reporting Rani Therapeutics (1856725) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2026 5:20 PM | McKinley Kate (1979211) Reporting Rani Therapeutics (1856725) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 4:47 PM | Rani Therapeutics (1856725) Subject Samsara BioCapital, L.P. (1699737) Filed by | Form SCHEDULE 13D/A | |
| 05/26/2026 7:38 PM | Rani Therapeutics (1856725) Filer | Form 424B5 | |
| 05/26/2026 7:41 PM | Rani Therapeutics (1856725) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 10:31 AM | Rani Therapeutics (1856725) Subject SymBiosis Capital Partners, LLC (2006045) Filed by | Form SCHEDULE 13G/A | |
| 04/30/2026 11:57 AM | Rani Therapeutics (1856725) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/16/2026 3:46 PM | Rani Therapeutics (1856725) Filer | Form DEF 14A | |
| 04/16/2026 3:48 PM | Rani Therapeutics (1856725) Filer | Form DEFA14A | |
| 04/16/2026 3:51 PM | Rani Therapeutics (1856725) Filer | Form ARS | |
| 03/27/2026 6:47 PM | Javadi Alireza (2123843) Reporting Rani Therapeutics (1856725) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/27/2026 10:33 AM | Rani Therapeutics (1856725) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/26/2026 3:46 PM | Rani Therapeutics (1856725) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/26/2026 3:43 PM | Rani Therapeutics (1856725) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/26/2026 3:10 PM | Rani Therapeutics (1856725) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/13/2026 11:31 AM | AWM Investment Company, Inc. (1535264) Filed by Rani Therapeutics (1856725) Subject | Form SCHEDULE 13G | |
| 02/12/2026 12:45 PM | Rani Therapeutics (1856725) Subject SymBiosis Capital Partners, LLC (2006045) Filed by | Form SCHEDULE 13G | |
| 01/30/2026 1:44 PM | Rani Therapeutics (1856725) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G | |
| 01/02/2026 4:27 PM | Rani Therapeutics (1856725) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/05/2025 3:05 PM | Rani Therapeutics (1856725) Filer | Form DEF 14C | |
| 12/03/2025 11:15 PM | Rani Therapeutics (1856725) Filer | Form EFFECT | |